External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Issue 10215 (14th December 2019)
- Record Type:
- Journal Article
- Title:
- External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Issue 10215 (14th December 2019)
- Main Title:
- External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial
- Authors:
- Whelan, Timothy J
Julian, Jim A
Berrang, Tanya S
Kim, Do-Hoon
Germain, Isabelle
Nichol, Alan M
Akra, Mohamed
Lavertu, Sophie
Germain, Francois
Fyles, Anthony
Trotter, Theresa
Perera, Francisco E
Balkwill, Susan
Chafe, Susan
McGowan, Thomas
Muanza, Thierry
Beckham, Wayne A
Chua, Boon H
Gu, Chu Shu
Levine, Mark N
Olivotto, Ivo A
Leong, Carson
Lester, Beverly Helen
Kwan, Winkle Bingchung
Abd-El-Malek, Medhat Zikry
Cheung, Arthur
Almahmudi, Maha
Broomfield, Joel
Sia, Michael
Reed, Melanie Jean
Wilson, Jane
Mohamed, Islam Gharib
Holloway, Caroline
Mills, Kenneth
Petrik, David W.
Crook, Juanita Mary
Wong, Frances Lai-Wah
Mills Carolan, Hannah
Voduc, David
Ingledew, Paris-Ann
Nguyen, Sonia
Keyes, Mira
Weir, Lorna M.
Tyldesley, Scott
Lim, Peter
Aquino Parsons, Christina
Olson, Robert
Blood, Paul
Wai, Elaine Sze-Sze
Truong, Pauline
Kader, Hosam (Sam)
Alexander, Abraham
Mohd Mydin, Aminudin Rahman
Smith, Sally
Vlachaki, Maria
Panet-Raymond, Valerie
Lupe, Krystine
Goulart, Jennifer
Nguyen, David
Chu, Karen
Canavan, Joycelin
Caon, Julianna
Tyler, Susan
Shahid, Negin
Lam, Jacqueline
Amanie, John
Severin, Diane Marie
Abdul Karim, Bassam
Tankel, Keith
Pervez, Nadeem
Joseph, Kurian
Gabos, Zsolt
Krause, Barbara
Huang, Fleur
Phan, Tien
Craighead, Peter
Yan, Elizabeth
MacKinnon, J.A. (Jack)
Nordal, Robert
Husain, Siraj
Voroney, Jon-Paul
Sinha, Richie
Pinilla, James
Cooke, Andrew
Vijayraghavan, Kalyani
Latosinsky, Steven
Saettler, Elizabeth
Lau, Yiu-Keung (James)
Krahn, Marianne
MacIntosh, Ethel
Nashed, Maged
Bashir, Bashir
Torri, Vamsee
Goldenberg, Benjamin
Kim, Christina
Basrur, Vasanth
Rachakonda, Ramana
Gopaul, Darin
Shahi, Sundeep
Kobeleva, Sofya
Dayes, Ian
Hodson, David
Strang, Barbara
Voruganti, Sachi
McMillan, William
Reiter, Harold
Wright, Jim
Sussman, Jonathan
Mukherjee, Som
Gudelis, Susan
D'Souza, David
Lock, Michael
Read, Nancy
Vujovic, Olga
Yaremko, Brian
Yu, Edward
Vandenberg, Theodore
Younus, Jawaid
Potvin, Kylea
Sexton, Tracy
Dingle, Brian
Findlay, Brian
Giesbrecht, Janice
Hughes, Philip
Samosh, Martin
Levesque, Michael
Yelamanchili, Radhika
Lee, Linda
VanderMeer, Rachel
Wasserman, David
Bowen, Julie
Want, David
Bissett, Randall
Andronowski, Adam
Shehata, Sarwat
Prichard, Hugh L.
Koll, Wayne
Chan, Philip C.
Mui, Jimmy
Youssef, Youssef M.
Campbell, Holly
El-Mallah, Medhat
Iqbal, Fawaad
Banihashemi, Behzad (Sayed)
Dixon, Peter
Grimard, Laval
Lochrin, Catherine
Meng, Joanne
Cross, Peter
El-Sayed, Samy
Esche, Bernd
Genest, Paul
Caudrelier, Jean-Michel
Morgan, Scott
Bourque, Jean-Marc
Nair, Vimoj
Senthelal, Senti
Jones, Glenn
Tsao, Jonathan
Radwan, John
Hayter, Charles
Finlay, Marisa
Lian, JD (Jidong)
Wang, Yongjin
Yuen, Jasper
Khan, Luleul
Cho, B.C. John
Koch, Christine Anne
Liu, Fei-Fei
Manchul, Lee Ann
McLean, Michael
Catton, Pamela
Dinniwell, Robert E.
Wells, Woodrow A.
Levin, Wilfred
Walsh, Lorraine
Chung, Caroline
Han, Kathy
Conrad, Tatiana
Helou, Joelle
Barry, Aisling
Schneider, Ken
Hirmiz, Khalid
Abu-Zahra, Hakam T.
Roy, Isabelle
Ayllon, Jose
Del Vecchio, Pierre
Fortin, Marie-Andrée
Guay, Jean-Pierre
Methot, Francis
Rousseau, Pierre
Jolicoeur, Marjory
Vu, Toni
Igidbashian, Levon
Dagnault, Anne
Diaz de Bedoya, Luis-Victor
Wang, Chang Shu
Fortin, Andre
Vigneault, Eric
Vallieres, Isabelle
Raymond, Paul-Emile
Martin, Andre-Guy
Blondeau, Lucie
Larochelle, Marie
Lessard, Nathalie
Gaudreault, Melanie
Théberge, Valerie
Nabid, Abdenour
Ballivy, Olivier
Bujold, Rachel
Ebacher, Annie
Provencher, Sawyna
Chabot, Pierre
Lemaire, Celine
Vavassis, Peter
Menkarios, Cathy
Yassa, Michael
Sultanem, Khalil
Panasci, Lawrence
Melnychuk, David
Patenaude, Francois
Miller, Wilson
Mihalioiu, Catalin
Ahlgren, Paul
Dalfen, Richard
Langleben, Adrian
Stern, Donna
Wan, Jonathan
Lambert, Christine
David, Marc
Kopek, Neil
Carbonneau, Annie
Hijal, Tarek
Grant, Nancy
Naz, Farah
Mohiuddin, M.D.
Kumar, S. Eshwar
Rutledge, Robert
Rheaume, Dorianne Elizabeth
Nolan, Maureen C.
Cwajna, Wladyslawa
Gill, Suki
Gleisner, Tracie
Grenfell, Solveig
Bishop, Michelle
Thiruthaneeswaran, Niluja
Liu, Chen
Philips, Claire
Drummond, Roslyn
King, Bronwyn
David, Steven P.
Dwyer, Mary K.
Campbell, Gillian
Brooks, Susan
Arunachalam, Ramesh
Sasso, Giuseppe
Benjamin, Chelleraj
Jose, Chakiath
Elder, Christine
Krawitz, Hedley
Lee, Dominique
Huang, Roger
Purchuri, Sudha
Pearse, Maria
Hemanth, Thayavalappil
Angell, Ruth
Patel, Vikash
Round, Glenys
Chaudhuri, Anupam
Ford, Christopher
… (more) - Abstract:
- Summary: Background: Whole breast irradiation delivered once per day over 3–5 weeks after breast conserving surgery reduces local recurrence with good cosmetic results. Accelerated partial breast irradiation (APBI) delivered over 1 week to the tumour bed was developed to provide a more convenient treatment. In this trial, we investigated if external beam APBI was non-inferior to whole breast irradiation. Methods: We did this multicentre, randomised, non-inferiority trial in 33 cancer centres in Canada, Australia and New Zealand. Women aged 40 years or older with ductal carcinoma in situ or node-negative breast cancer treated by breast conserving surgery were randomly assigned (1:1) to receive either external beam APBI (38·5 Gy in ten fractions delivered twice per day over 5–8 days) or whole breast irradiation (42·5 Gy in 16 fractions once per day over 21 days, or 50 Gy in 25 fractions once per day over 35 days). Patients and clinicans were not masked to treatment assignment. The primary outcome was ipsilateral breast tumour recurrence (IBTR), analysed by intention to treat. The trial was designed on the basis of an expected 5 year IBTR rate of 1·5% in the whole breast irradiation group with 85% power to exclude a 1·5% increase in the APBI group; non-inferiority was shown if the upper limit of the two-sided 90% CI for the IBTR hazard ratio (HR) was less than 2·02. This trial is registered with ClinicalTrials.gov, NCT00282035 . Findings: Between Feb 7, 2006, and July 15, 2011,Summary: Background: Whole breast irradiation delivered once per day over 3–5 weeks after breast conserving surgery reduces local recurrence with good cosmetic results. Accelerated partial breast irradiation (APBI) delivered over 1 week to the tumour bed was developed to provide a more convenient treatment. In this trial, we investigated if external beam APBI was non-inferior to whole breast irradiation. Methods: We did this multicentre, randomised, non-inferiority trial in 33 cancer centres in Canada, Australia and New Zealand. Women aged 40 years or older with ductal carcinoma in situ or node-negative breast cancer treated by breast conserving surgery were randomly assigned (1:1) to receive either external beam APBI (38·5 Gy in ten fractions delivered twice per day over 5–8 days) or whole breast irradiation (42·5 Gy in 16 fractions once per day over 21 days, or 50 Gy in 25 fractions once per day over 35 days). Patients and clinicans were not masked to treatment assignment. The primary outcome was ipsilateral breast tumour recurrence (IBTR), analysed by intention to treat. The trial was designed on the basis of an expected 5 year IBTR rate of 1·5% in the whole breast irradiation group with 85% power to exclude a 1·5% increase in the APBI group; non-inferiority was shown if the upper limit of the two-sided 90% CI for the IBTR hazard ratio (HR) was less than 2·02. This trial is registered with ClinicalTrials.gov, NCT00282035 . Findings: Between Feb 7, 2006, and July 15, 2011, we enrolled 2135 women. 1070 were randomly assigned to receive APBI and 1065 were assigned to receive whole breast irradiation. Six patients in the APBI group withdrew before treatment, four more did not receive radiotherapy, and 16 patients received whole breast irradiation. In the whole breast irradiation group, 16 patients withdrew, and two more did not receive radiotherapy. In the APBI group, a further 14 patients were lost to follow-up and nine patients withdrew during the follow-up period. In the whole breast irradiation group, 20 patients were lost to follow-up and 35 withdrew during follow-up. Median follow-up was 8·6 years (IQR 7·3–9·9). The 8-year cumulative rates of IBTR were 3·0% (95% CI 1·9–4·0) in the APBI group and 2·8% (1·8–3·9) in the whole breast irradiation group. The HR for APBI versus whole breast radiation was 1·27 (90% CI 0·84–1·91). Acute radiation toxicity (grade ≥2, within 3 months of radiotherapy start) occurred less frequently in patients treated with APBI (300 [28%] of 1070 patients) than whole breast irradiation (484 [45%] of 1065 patients, p<0·0001). Late radiation toxicity (grade ≥2, later than 3 months) was more common in patients treated with APBI (346 [32%] of 1070 patients) than whole breast irradiation (142 [13%] of 1065 patients; p<0·0001). Adverse cosmesis (defined as fair or poor) was more common in patients treated with APBI than in those treated by whole breast irradiation at 3 years (absolute difference, 11·3%, 95% CI 7·5–15·0), 5 years (16·5%, 12·5–20·4), and 7 years (17·7%, 12·9–22·3). Interpretation: External beam APBI was non-inferior to whole breast irradiation in preventing IBTR. Although less acute toxicity was observed, the regimen used was associated with an increase in moderate late toxicity and adverse cosmesis, which might be related to the twice per day treatment. Other approaches, such as treatment once per day, might not adversely affect cosmesis and should be studied. Funding: Canadian Institutes for Health Research and Canadian Breast Cancer Research Alliance. … (more)
- Is Part Of:
- Lancet. Volume 394:Issue 10215(2019)
- Journal:
- Lancet
- Issue:
- Volume 394:Issue 10215(2019)
- Issue Display:
- Volume 394, Issue 10215 (2019)
- Year:
- 2019
- Volume:
- 394
- Issue:
- 10215
- Issue Sort Value:
- 2019-0394-10215-0000
- Page Start:
- 2165
- Page End:
- 2172
- Publication Date:
- 2019-12-14
- Subjects:
- Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Medicine
Electronic journals
Periodicals
610.5 - Journal URLs:
- http://www.thelancet.com/ ↗
http://www.sciencedirect.com/science/journal/01406736 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0140-6736(19)32515-2 ↗
- Languages:
- English
- ISSNs:
- 0140-6736
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5146.000000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22879.xml